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Abstract: Primary care facilities may be a natural setting for delivering interventions that 
focus on behaviors that improve cardiovascular disease (CVD) risk factors. The purpose of this 
study was to examine the 24-month effects of the Activity Counseling Trial (ACT) on CVD risk 
factors, to examine whether changes in CVD risk factors differed according to baseline risk 
factor status, and to examine whether changes in fitness were associated with changes in CVD 
risk factors. ACT was a 24-month multicenter randomized controlled trial to increase physical 
activity. Participants were 874 inactive men and women aged 35–74 years. Participants were 
randomly assigned to one of three arms that varied by level of counseling, intensity, and resource 
requirements. Because there were no significant differences in change over time between arms on 
any of the CVD risk factors examined, all arms were combined, and the effects of time, indepen-
dent of arm, were examined separately for men and women. Time × Baseline risk factor status 
interactions examined whether changes in CVD risk factors differed according to baseline risk 
factor status. Significant improvements in total cholesterol, high-density lipoprotein cholesterol 
(HDL-C) and low-density lipoprotein cholesterol, the ratio of total cholesterol to HDL-C, and 
triglycerides were seen in both men and women who had high (or low for HDL-C) baseline 
levels of risk factors, whereas significant improvements in diastolic blood pressure were seen 
only in those men with high baseline levels. There were no improvements in any risk factors 
among participants with normal baseline levels. Changes in fitness were associated with changes 
in a number of CVD risk factors. However, most relationships disappeared after controlling 
for changes in body weight. Improvements in lipids from the ACT interventions could reduce 
the risk of coronary heart disease in people with already high levels of lipids by 16%–26% in 
men and 11%–16% in women. Interventions that can be implemented in health care settings 
nationwide and result in meaningful population-wide changes in CVD risk factors are needed. 
The ACT physical activity interventions produced substantial improvements among men and 
women with elevated CVD risk factors.
Keywords: primary care counseling, cardiovascular disease risk factors, physical activity, 
  fitness, behavioral intervention
Introduction
Cardiovascular disease (CVD) accounts for 25% of all deaths in the US.1   Hypertension2 
and hyperlipidemia3 are two established risk factors for CVD. Results from the 
National Health and Nutrition Examination Survey (NHANES) indicate that among 
adults aged 20 years and older, 21% have elevated low-density lipoprotein cholesterol 
(LDL-C)4 and 29% have hypertension ($140/90 mm Hg).5 Physical activity (PA), 
a major modifiable risk factor for CVD, is associated with a decreased risk for both 
hypertension6 and deleterious lipid levels.7International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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CVD is a serious public health burden in terms of 
life-years lost, reduced quality of life, and medical costs.8 
Potentially low-cost interventions that can be successfully 
implemented population-wide and result in reductions in 
CVD risk factors should be a public health priority. Numerous 
behavioral interventions targeting CVD risk factor reduction 
through PA, diet, weight loss, and/or other lifestyle changes, 
either as primary or secondary outcomes, have been reported. 
Most have targeted multiple lifestyle factors including diet 
and PA,9–25 whereas fewer have focused exclusively on 
PA.26–30 Systematic reviews of randomized controlled trials 
have found that aerobic exercise significantly lowers blood 
pressure6,31 and improves lipids and lipoproteins.32,33
Primary care facilities are a natural setting for delivering 
interventions to improve CVD risk factors. Primary care 
settings have the potential to reach large numbers of people, 
as nearly 87% of US adults see a health care professional 
at least one time a year, and nearly 25% have at least four 
visits a year.34 Visits to a primary care facility offer a “teach-
able moment” in which behavior change can be discussed. 
Despite the appeal of behavioral interventions in primary care 
settings, a recent review concluded that lifestyle counseling 
interventions delivered in these settings have marginal benefit 
in changing CVD risk factors in low-risk patients.35 Of the 
studies that included PA as a part of the lifestyle interven-
tion in the review, three of six found small but significant 
benefits for blood pressure,22,24,25 and one of four found small 
but significant benefits for cholesterol.25
The Activity Counseling Trial (ACT) was a 2-year 
  multicenter randomized controlled trial delivered in   primary 
care settings that evaluated the effects of three levels of PA 
counseling on cardiorespiratory fitness (fitness) and PA.36,37 
Secondary outcomes included the CVD risk factors of resting 
blood pressure, lipids, and lipoproteins. Primary outcomes 
have been reported elsewhere.38 Briefly, women in the 
two intervention arms receiving physician advice plus 
counseling from a health educator had significantly greater 
improvements in fitness compared with the physician-advice-
only comparison arm at 24 months. Differences in fitness for 
men did not differ across intervention arms; all three arms 
improved over the 24-month study period.38 The purpose of 
this paper is to: 1) examine the effects of the ACT interven-
tions on CVD risk factors, ie, systolic blood pressure (SBP) 
and diastolic blood pressure (DBP), lipoproteins (total cho-
lesterol [TC], high-density lipoprotein cholesterol [HDL-C], 
LDL-C, the ratio of TC to HDL-C, and triglycerides; 
2) examine whether changes in CVD risk factors differed 
according to baseline risk factor status (high versus normal); 
3) examine whether changes in fitness were associated with 
changes in CVD risk factors; and 4) examine whether changes 
in weight explained associations between changes in fitness 
and changes in CVD risk factors.
Methods
Detailed descriptions of ACT have been published.36–38 
  Participants were recruited over an 18-month period 
(1995–1997) from 10 primary care facilities, involving 
51 physicians, four physician assistants, and one nurse 
  practitioner.38 Participants were inactive adults, aged 
35–75 years, in stable health, planning and/or scheduled to 
see their primary care health professional during recruitment, 
able to read and write in English, independent in their daily 
living, and able to increase their PA levels.37
The primary care facilities used for recruitment were 
affiliated with three clinical centers: Stanford University, 
the University of Tennessee, and the Cooper Institute in 
conjunction with the University of Texas Southwestern 
  Medical Center. The ACT coordinating center was Wake 
Forest University School of Medicine, and the project office 
was the National Heart, Lung, and Blood Institute.38 The ACT 
study was approved yearly by each of the institutional review 
boards from the clinical and coordinating centers.
Intervention
After baseline assessments, participants were randomly 
assigned to one of three treatment arms that varied by 
level of counseling, intensity, and resource requirements: 
physician/health care provider advice (ie, optimal standard 
care), assistance, and counseling.36 Social cognitive theory 
(SCT)39 and the transtheoretical model (TTM)40 guided the 
ACT intervention.36 With the exception of physician advice, 
the intervention was delivered by ACT health educators.38 
All three arms were given the same PA goals, based on the 
national recommendations of 5 or more days of 30 minutes 
or more of moderate intensity PA41 or 3 or more days of 
30 minutes or more of vigorous intensity PA.42
Participants in the standard care or “advice” arm received 
brief counseling (2–4 minutes) from their primary care pro-
vider on the recommended amount of PA and were given 
standard written materials on PA guidelines from the ACT 
health educator.36,38 Participants in this arm were invited to 
call the health educator with any questions regarding their 
PA program (eg, type or amount of PA); however, behavioral 
counseling was not provided.36,38
Participants randomized to the staff assistance   intervention 
or “assistance” arm received the same provider advice and International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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educational materials as the advice arm, plus a 30–40   minute 
counseling session with a health educator and monthly 
theory-based, behavior change-oriented interactive mailed 
newsletters.36,38 The interactive mail component was intended 
to increase cognitive and behavioral skills for increasing 
PA.36,38 Each newsletter included a postage-paid mail-back 
card for reporting weekly PA, current goals, and barriers 
to PA. After receiving the mail-back card, health educators 
sent the participants feedback sheets addressing the specific 
barriers they encountered.36,38 Participants in this arm also 
received an electronic pedometer and calendar to encourage 
self-monitoring, inexpensive incentives, and brief behavioral 
counseling from the health educators at each subsequent 
naturally occurring visit to his or her physician.36,38
Participants in the staff-counseling intervention or 
“  counseling” arm received everything the advice and 
  assistance arms received plus health educator-initiated 
  telephone counseling biweekly for the first 6 weeks, then 
monthly for the remainder of the first year. During the 
second year, the health educator and participant decided 
together how frequent the subsequent counseling calls 
would be.36,38 Weekly behavior change classes conducted 
by the health educators were also offered to participants 
in this intervention arm. The classes focused primarily on 
  building the cognitive and behavioral skills needed to adopt 
and maintain PA.36,38
Clinical measures
Demographic variables
Participants reported their age, gender, race/ethnicity, current 
marital status, income, highest grade of school completed, 
and whether they were currently taking medications for 
hypertension or elevated cholesterol.43
Body mass index
Height to the nearest 1/10 centimeter and weight to the 
  nearest 1/10 kilogram were measured by trained staff and 
body mass index (BMI) was calculated.
Lipids and lipoproteins
Blood samples were drawn after an overnight fast and 
  analyzed in a central laboratory for TC, HDL-C, LDL-C 
  (calculated from the Friedewald equation44), and triglycerides. 
The ratio of TC to HDL-C was calculated for analyses.
Blood pressure
After participants sat quietly for 5 minutes, resting SBP and 
DBP was measured three times using a standard   mercury 
sphygmomanometer. The average of the second and 
third measures was used for statistical analyses.
Cardiorespiratory fitness
Fitness was assessed by measuring maximal oxygen uptake 
(VO2 max, mL/kg/min) using a graded maximal exercise test 
on a treadmill at the baseline and 24-month visits. After partici-
pants warmed up with a brief walk at a 0% grade, the speed was 
increased until steady-state heart rate of 60% of age-predicted 
maximum or a rating of 11–13 on the Borg scale45 of perceived 
exertion was maintained for 4 minutes. Then, treadmill grade 
was elevated 2% in 2-minute stages until the rate of perceived 
exertion (RPE) reached 17 or above, thereafter increasing the 
grade by 1% until the participant reached volitional fatigue or 
standard stopping criteria.46
Statistical analyses
The original study was powered to test outcomes for men and 
women separately.37,38 Therefore, all analyses were stratified 
by sex. All statistical analyses were performed using SAS 
(version 9.2; SAS Institute, Cary, NC). Repeated measures 
ANOVA procedures (using SAS PROC MIXED) were used 
to examine change over time in SBP, DBP, TC, HDL-C, 
LDL-C, TC to HDL-C ratio, and triglycerides. Because 
Group × Time interactions revealed no significant differences 
in change over time between study arms on any of the CVD 
risk   factors examined, this term was removed from all models, 
and the effects of time, independent of arm, were examined. 
All models controlled for arm, race/  ethnicity, education, age, 
sex, baseline BMI, and clinical site. The same set of models 
for each outcome variable was repeated,   adding medication 
intake as a time-varying covariate (blood   pressure   medication 
[yes/no] for SBP and DBP models; and high cholesterol 
  medication [yes/no] for TC, HDL-C, LDL-C, TC to HDL-C 
ratio, and triglycerides models). Finally, Time × Baseline 
risk factor status interactions (high versus normal, except 
HDL-C, which was classified as low versus normal) examined 
whether changes in CVD risk factors differed according to 
baseline risk factor status. “High” was defined as the fol-
lowing: SBP $ 140, DBP $ 90, TC $ 240, TC to HDL-C 
ratio $5:1, LDL-C $160, and triglycerides $200, whereas 
“low” was defined as HDL-C ,40 for men and ,50 for 
women. Participants who reported being on blood pressure 
or high cholesterol medication at baseline were classified as 
“high” (or “low” for HDL-C) for the corresponding blood 
pressure and/or cholesterol analyses.
ANCOVA models (SAS PROC GLM) examined the rela-
tionship between changes in each of the secondary outcomes International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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and changes in fitness, independent of arm assignment. 
Because changes in weight may be related to changes in CVD 
risk factors and thus potentially confound fitness–CVD risk 
factor relationship, we also examined the relationship between 
changes in the secondary outcomes and changes in weight. To 
test the independent effects of each, both variables (ie, changes 
in fitness and weight) were entered simultaneously into the 
model. A separate model, controlling for the same covariates 
above, was conducted for each of the CVD risk factors.
Results
Participants were 479 men and 395 women with a mean age 
of 51.2 ± 9.7 years for women and 50.7 ± 9.6 years for men 
(Table 1). There were no differences between intervention arms 
on key demographic variables for women or men. At baseline, 
36% of women and 34% of men were classified as hypertensive 
(SBP $ 140 mm Hg, DBP $ 90 mm Hg or taking antihyper-
tensive medication) and 21% of women and 26% of men had 
hyperlipidemia (LDL-C $ 160 mg/dL or taking lipid-lowering 
medication). There were no differences between groups on any 
CVD risk factors at baseline for either gender (Table 2).
changes in cVD risk factors: women
Table 2 shows the adjusted means for each CVD risk factor at 
baseline and 24 months for women. Results showed a signifi-
cant increase in SBP (P = 0.004). There were no significant 
changes in DBP (P = 0.83), TC (P = 0.45), HDL-C (P = 0.90), 
LDL-C (P = 0.42), the TC to HDL-C ratio (P = 0.90), or 
triglycerides (P = 0.99). Models adjusting for medication 
intake did not significantly change the results for any of the 
risk factors (data not shown).
Table 3 shows whether changes in CVD risk factors dif-
fered by baseline risk factor status. Significant Time × Base-
line risk factor status interactions were found for all CVD 
risk factors (P , 0.0001 for all). SBP significantly increased 
among participants with high SBP at baseline (P = 0.01) but 
not among those with normal blood pressure (P = 0.13). TC 
significantly decreased among participants with high TC at 
baseline (P , 0.0001), but significantly increased among par-
ticipants with normal TC at baseline (P = 0.04). HDL-C signif-
icantly increased in participants with low HDL-C at baseline 
(P = 0.01), but did not change among those with normal 
baseline HDL-C (P = 0.05). There were significant decreases 
in LDL-C (P , 0.0001), the TC to HDL-C ratio (P = 0.01), 
and triglycerides (P = 0.001) among participants with high 
corresponding baseline levels, but not among   participants with 
normal levels (P = 0.07, P = 0.08, and P = 0.11, respectively). 
Finally, although DBP was   significantly different among those 
Table  1  Baseline  characteristics  of  men  and  women  in  the 
Activity counseling Trial
Women 
(n = 395)
Men 
(n = 479)
N % or 
Mean ± SD
N % or 
Mean ± SD
Age 395 51.2 ± 9.7 479 50.7 (9.6)
race
  White 253 64.4 344 72.6
  Black 121 30.8 96 20.3
  Other 19 4.8 34 7.2
education
   ,high school  
graduate
33 8.4 14 2.9
    high school  
graduate
61 15.4 30 6.3
  some college 158 40.0 87 18.2
  college graduate 76 19.2 155 32.4
  Postgraduate 67 17.0 193 40.3
Income (UsD, per 
annum)
  ,$30,000 135 35.6 56 11.9
    $30,000 to 
,$50,000
91 24.0 61 13.0
    $50,000 to 
,$75,000
63 16.6 97 20.6
    $75,000 to 
,$100,000
40 10.6 85 18.1
  $100,000+ 50 13.2 172 36.5
employment status
  employed 275 69.8 40913 85.4
  Unemployed 19 4.8 46 2.7
  retired 43 10.9 11 9.6
  homemaker 46 11.7 n/a 2.3
  Other 11 2.8 n/a n/a
current smoker
  Yes 40 10.2 38 7.9
  no 353 89.8 441 92.1
BMI (kg/m2) 389 30.4 ± 7.2 475 28.9 ± 5.2
VO2 max (mL/kg/min) 395 20.7 ± 5.4 479 28.8 ± 6.5
hypertension
  Yes 141 35.7 163 34.0
  no 254 64.3 316 66.0
hyperlipidemia
  Yes 80 21.2 120 25.8
  no 297 78.8 345 74.2
Abbreviations: BMI, body mass index; sD, standard deviation; n/a, not applicable; 
VO2 max, maximal oxygen uptake.
with high and normal baseline levels, neither group changed 
significantly over time.
changes in cVD risk factors: men
Table 2 shows the adjusted means for each CVD risk factor 
examined at baseline and 24 months for men. Results showed 
a significant decrease in DBP (P = 0.0002), TC (P , 0.0001), 
LDL-C (P , 0.0001), the TC to HDL-C ratio (P = 0.01), and International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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triglycerides (P = 0.01). There were no significant changes 
in SBP (P = 0.70) or HDL-C (P = 0.78). Models adjusting 
for medication intake did not significantly change the results 
for any of the risk factors (data not shown).
Table 3 shows whether changes in CVD risk factors dif-
fered by baseline risk factor status. Significant Time × Baseline 
risk factor status interactions were found for all CVD risk fac-
tors (P , 0.0001 for all). There were significant decreases in 
DBP (P , 0.0001), TC (P , 0.0001), LDL-C (P , 0.0001), 
the TC to HDL-C ratio (P , 0.0001), and triglycerides 
(P , 0.0001) among participants with high corresponding 
baseline levels but not among participants with normal levels 
(P = 0.08, P = 0.09, P = 0.64, P = 0.22, P = 0.62, respectively). 
HDL-C significantly increased in participants with low HDL-C 
at baseline (P = 0.04) but did not change among those with 
normal baseline HDL-C (P = 0.06). Finally, although SBP was 
significantly different among those with high and normal base-
line levels, neither group significantly changed over time.
Associations between changes in fitness, 
weight, and cVD risk factors: women
There were a number of significant associations between 
changes in CVD risk factors and changes in fitness and 
weight in women participating in ACT (Table 4). An increase 
in fitness from baseline to 24 months was associated with 
a significant decrease in TC (P = 0.01) and triglycerides 
(P = 0.03) from baseline to 24 months. A decrease in 
weight from baseline to 24 months was associated with a 
decrease in SBP (P = 0.002), DBP (P = 0.0003), the TC 
to HDL-C ratio (P = 0.01), and triglycerides (P = 0.003), 
and an increase in HDL-C (P , 0.0001) from baseline to 
24 months. When changes in fitness and changes in weight 
were entered simultaneously into the model, only one result 
changed: an increase in fitness was no longer associated 
with a decrease in triglycerides after controlling for change 
in weight (P = 0.17).
Associations between changes in fitness, 
weight, and cVD risk factors: men
There were a number of significant associations between 
changes in CVD risk factors and changes in fitness and 
weight in men participating in the ACT (Table 4). An increase 
in fitness from baseline to 24 months was associated with a 
significant decrease in the TC to HDL-C ratio (P = 0.004) 
and triglycerides (P = 0.003), and an increase in HDL-C 
(P = 0.003) from baseline to 24 months. There was also a 
borderline significant relationship in the expected direction 
for DBP (P = 0.06). A decrease in weight from baseline to 
Table 2 cardiovascular disease risk factors at each assessment time for women and men
Women Men
Mean (SE) % change P-value Mean (SE) % change P-value
sBP, mm hg
  Baseline 117.2 (1.8) 1.6 0.004 122.6 (1.1) -0.16 0.70
  24 months 119.1 (1.8) 122.4 (1.1)
DBP, mm hg
  Baseline 74.4 (1.1) 0.13 0.83 80.7 (0.69) -1.6 0.002
  24 months 74.5 (1.1) 79.4 (0.70)
Tc, mg/dL
  Baseline 194.9 (5.0) -0.62 0.45 204.3 (3.2) -4.4 ,0.0001
  24 months 193.7 (5.1) 195.6 (3.3)
hDL-c, mg/dL
  Baseline 50.9 (1.9) 0.0 0.90 41.7 (0.91) 0.24 0.78
  24 months 50.9 (1.9) 41.8 (0.92)
LDL-c, mg/dL
  Baseline 121.2 (4.6) -1.0 0.42 132.5 (2.9) -5.2 ,0.0001
  24 months 120.0 (4.6) 126.0 (2.9)
Tc/hDL-c
  Baseline 4.2 (0.17) 0.0 0.90 5.2 (0.14) -4.0 0.005
  24 months 4.2 (0.18) 5.0 (0.14)
Triglycerides, mg/dL
  Baseline 114.2 (9.2) 0.09 0.99 150.3 (9.1) -8.1 0.01
  24 months 114.1 (9.3) 139.1 (9.2)
Note: All models controlled for group, race, education, age, sex, and clinical site.
Abbreviations: DBP, diastolic blood pressure; hDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; sBP, systolic blood pressure;   
se, standard error; Tc, total cholesterol.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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24 months was associated with a decrease in SBP (P = 0.003), 
DBP (P , 0.0001), TC (P , 0.0001), the TC to HDL-C ratio 
(P , 0.0001), and triglycerides (P # 0.0001), and an increase 
in HDL-C (P = 0.008) from baseline to 24 months. There 
were no other significant relationships for any other CVD 
risk factors examined. When changes in fitness and weight 
were entered simultaneously into the model, results did not 
change for weight, with the exception of HDL-C, which was 
no longer related to decreases in weight (P = 0.09). Although 
HDL-C (P = 0.04) remained significant, changes in the TC 
to HDL-C ratio (P = 0.20) and triglycerides (P = 0.19) were 
no longer associated with changes in fitness. The borderline 
relationship of fitness to DBP also disappeared (P = 0.60).
Discussion
Intervention approaches that can be successfully dissemi-
nated and result in meaningful reductions in CVD risk factors 
are needed. This study evaluated the effects of three levels of 
a PA intervention delivered in primary care settings on CVD 
risk factors. Several risk factor improvements were achieved, 
irrespective of intervention assignment, for men and women 
with unfavorable baseline levels of CVD risk factors, but not 
for those with normal baseline levels.
The lack of significant differences between intervention 
arms over time should not be interpreted as unsuccessful 
intervention approaches. Although the advice arm was 
considered the “control arm”, there really was not a true 
control arm in ACT. All participants (including those in the 
advice arm) received 2–4 minutes of PA counseling from a 
  physician/health care provider in addition to written materials 
about PA from a health educator. Although physician advice 
about PA is recommended as part of standard practice,47   
a majority of physicians are not counseling patients on PA.48 
Furthermore, all participants completed extensive assess-
ments throughout the course of the trial, including repeated 
maximal exercise tests, which could have influenced moti-
vation to change behavior.49 Finally, many participants in 
ACT were recruited through physician-signed letters which 
could have also provided additional behavioral motivation 
in all arms.
Significant improvements in CVD risk factors were seen 
in both men and women who had high (or low for HDL-C) 
baseline levels of CVD risk factors, with the exception of 
SBP, which did not change in men or women, and DBP, 
which only improved in men. However, none of the CVD risk 
factors improved among participants with normal baseline 
Table 3 cardiovascular disease risk factors for women and men at baseline and 24 months, by baseline risk factor level
Women Men
Baseline 24 months Baseline 24 months
Mean (SE) Mean (SE) % change P-value 
Interaction
Mean (SE) Mean (SE) % change P-value 
Interaction
sBP, mm hg
  normal 113.9 (1.8) 115.1 (1.8) 1.1 ,0.0001 119.3 (1.0) 119.0 (1.1) -0.25 ,0.0001
  high 121.1 (1.9) 124.3 (2.0)a 2.6 131.4 (1.3) 131.7 (1.4) 0.23
DBP, mm hg
  normal 72.6 (1.1) 72.5 (1.1) -0.14 ,0.0001 78.0 (0.69) 77.4 (0.70) -0.78 ,0.0001
  high 76.4 (1.1) 76.9 (1.2) 0.10 86.0 (0.83) 83.5 (0.86)a -3.0
Tc, mg/dL
  normal 186.2 (4.3) 189.5 (4.4)a 1.8 ,0.0001 193.7 (2.9) 190.8 (3.0) -1.5 ,0.0001
  high 240.7 (5.4) 223.5 (5.6)a -7.7 245.5 (3.9) 217.2 (4.1)a -13.0
hDL-c, mg/dL
  normal 60.0 (1.5) 58.5 (1.6) -2.6 ,0.0001 48.5 (0.81) 47.4 (0.84) -2.3 ,0.0001
  Low 41.0 (1.5) 43.0 (1.6)a 4.9 35.0 (0.81) 36.0 (0.83)a 2.9
LDL-c, mg/dL
  normal 113.5 (4.0) 116.3 (4.0) 2.5 ,0.0001 120.2 (2.6) 119.5 (2.7) 0.59 ,0.0001
  high 162.7 (5.0) 147.1 (5.1)a -10.6 165.0 (3.3) 142.2 (3.4)a -16.0
Tc/hDL-c
  normal 3.6 (0.14) 3.7 (0.15) 2.8 ,0.0001 4.0 (0.12) 4.1 (0.13) 2.5 ,0.0001
  high 5.5 (0.16) 5.2 (0.17)a 5.8 6.3 (0.12) 5.9 (0.12)a -6.8
Triglycerides, mg/dL
  normal 97.4 (7.6) 103.0 (7.8) 5.7 ,0.0001 110.1 (7.4) 112.6 (7.7) 2.3 ,0.0001
  high 214.4 (10.3) 184.2 (11.1)a -16.4 265.7 (9.5) 220.6 (9.9)a -20.4
Notes: aP , 0.05; All models controlled for group, race, education, age, sex, and clinical site.
Abbreviations: DBP, diastolic blood pressure; hDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; sBP, systolic blood pressure;   
se, standard error; Tc, total cholesterol.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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Table  4  Relationship  between  changes  in  CVD  risk  factors  and  1)  changes  in  fitness,  2)  changes  in  weight,  and  3)  changes  in   
fitness + weight
Women Men
Model I Model II Model I Model II
Estimate 
(SE)
P-value Estimate 
(SE)
P-value Estimate 
(SE)
P-value Estimate 
(SE)
P-value
sBP, mm hg
 Δ  Fitness -0.12 (0.22) 0.60 0.10 (0.23) 0.67 -0.14 (0.15) 0.33 0.03 (0.15) 0.87
 Δ  Weight 2.9 (0.09) 0.002 0.32 (0.10) 0.002 0.35 (0.12) 0.003 0.34 (0.13) 0.008
DBP, mm hg
 Δ  Fitness -0.12 (0.12) 0.32 0.01 (0.13) 0.96 -0.17 (0.09) 0.06 -0.05 (0.09) 0.60
 Δ  Weight 0.18 (0.05) 0.0003 0.20 (0.06) 0.0004 0.28 (0.07) ,0.0001 0.26 (0.08) 0.0008
Tc, mg/dL
 Δ  Fitness -1.22 (0.47) 0.01 -1.09 (0.50) 0.03 -0.72 (0.42) 0.08 -0.22 (0.44) 0.62
 Δ  Weight 0.27 (0.21) 0.20 0.24 (0.22) 0.28 1.45 (0.33) ,0.0001 1.40 (0.37) 0.0002
hDL-c, mg/dL
 Δ  Fitness 0.03 (0.19) 0.88 -0.22 (0.19) 0.25 0.31 (0.10) 0.003 0.24 (0.11) 0.04
 Δ  Weight -0.32 (0.08) ,0.0001 -0.37 (0.09) ,0.0001 -0.22 (0.08) 0.008 -0.16 (0.09) 0.09
LDL-c, mg/dL
 Δ  Fitness -0.81 (0.45) 0.08 -0.54 (0.48) 0.26 -0.28 (0.39) 0.48 -0.11 (0.42) 0.80
 Δ  Weight 0.36 (0.20) 0.08 0.42 (0.22) 0.05 0.50 (0.32) 0.11 0.51 (0.35) 0.15
Tc/hDL-c
 Δ  Fitness -0.03 (0.02) 0.13 -0.01 (0.02) 0.50 -0.05 (0.02) 0.004 -0.03 (0.02) 0.20
 Δ  Weight 0.02 (0.01) 0.01 0.02 (0.01) 0.01 0.08 (0.01)  0.0001 0.07 (0.02) ,0.0001
Triglycerides, mg/dL
 Δ  Fitness -2.23 (1.04) 0.03 -1.51 (1.09) 0.17 -3.69 (1.22) 0.003 -1.65 (1.27) 0.19
 Δ  Weight 1.38 (0.46) 0.003 1.18 (0.49) 0.02 5.88 (0.93) ,0.0001 5.19 (1.05) ,0.0001
Notes: All models controlled for group, race, education, age, sex, and clinical site. Model I tested the effects of Δ Fitness and Δ Weight separately. Model II entered Δ Fitness 
and Δ Weight in the model simultaneously, testing the independent effects of each.
Abbreviations: DBP, diastolic blood pressure; hDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; sBP, systolic blood pressure;   
se, standard error; Tc, total cholesterol.
levels. These results are not surprising, as participants with 
normal risk factors had less room for improvement. The 
significant improvements in participants with unfavorable 
baseline levels of risk factors are notable, as these individu-
als have the greatest need for meaningful reductions in risk 
factors and thus should be targeted in behavioral interventions 
focusing on CVD risk reduction.
DBP significantly decreased in men with high DBP at 
baseline. Although modest at the individual level (decrease 
of 2.5 mm Hg), this change should be interpreted within a 
public health context. A 2 mm Hg reduction in DBP applied 
across the population as a whole would reduce the preva-
lence of hypertension by 17%, and reduce the incidence of 
coronary heart disease (CHD) by 6% and incidence of 
stroke by 15%.50 The significant decreases in LDL-C, TC, 
triglycerides, and the TC to HDL-ratio, and the significant 
increase in HDL-C among men and women with high 
levels at baseline, are also encouraging. Adjusted levels of 
LDL-C decreased ∼11% in women and ∼16% in men, TC 
decreased ∼8% in women and ∼13% in men, triglycerides 
decreased ∼16% in women and ∼20% in men, and the TC 
to HDL-ratio decreased ∼5% in women and ∼7% in men, 
whereas HDL-C improved ∼5% in women and ∼3% in 
men. These changes are important and meaningful, as a 1% 
decrease in LDL-C is associated with a 1% reduction in the 
risk for CHD,51 whereas a 1% decrease in TC is associated 
with a 2% reduction in CHD risk.51 Improvements of this 
magnitude across the 21% of adults who have high LDL-C4 
and the 29% who have hypertension ($140/90 mm Hg)5 
would produce powerful public health benefit.
Results from other home-based and/or lifestyle PA 
intervention studies have found mixed results on CVD risk 
factors. For example, a study by King et al29 examining the 
effects of group- and home-based exercise programs on 
CVD risk factors found that although no effect was found 
at 1 year, there was a significant increase in HDL-C after 
2 years among participants in two telephone-assisted home-
based exercise training programs. However, there were no 
effects at either time point on TC, LDL-C, triglycerides, or 
blood pressure in this generally normotensive and nonhyer-
lipidemic sample of middle-aged adults. Dunn et al52 found 
significant decreases in SBP, DBP, TC, the TC to HDL-C International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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ratio, and triglycerides, but not in LDL-C and HDL-C at 
6 months among middle-aged participants in a lifestyle PA 
intervention group. However, SBP and DBP were the only 
risk factor reductions maintained at 24 months.26 Two other 
studies delivered in general practice settings by an exercise 
specialist28 and a general practitioner and exercise specialist30 
found significant within-group changes in CVD risk factors. 
However, differences between the intervention and control 
groups were not significant. Halbert et al28 found significant 
decreases in SBP and DBP in the intervention but not control 
group, whereas Elley et al30 found a decrease in TC, LDL-C, 
and triglycerides in both the intervention and control group, 
but no effects on blood pressure or HDL-C.
Changes in several CVD risk factors were associated with 
changes in fitness and weight. However, almost all of the sig-
nificant relationships for fitness disappeared after controlling 
for weight change. The exceptions were for HDL-C (men) 
and TC (women), which remained independently associated 
with changes in fitness. An observational study by Sternfeld 
et al53 also found significant associations between changes 
in TC, HDL-C, LDL-C, and triglycerides and changes in fit-
ness and weight over a 7-year period. When examining the 
independent effects of fitness, similar to the present results 
for men, HDL-C was the only risk factor that remained 
significant. Results from these studies suggest that much 
of the association between changes in fitness and lipids is 
accounted for by changes in weight.53 It is unclear whether 
weight change confounds the relationship between changes 
in fitness and CVD risk factors or if it is part of the pathway 
by which fitness and weight work together to influence CVD 
risk factors.53 However, the independent effects of fitness on 
HDL-C, and perhaps on TC, suggest that confounding alone 
may not explain these complex relationships.
This study has a number of strengths including the 
  objective measures of fitness, blood pressure, lipids, and lipo-
proteins. The large sample size also allowed   gender-specific 
analyses. We also recognize our study limitations. The 
  sample was predominantly highly educated and affluent, and 
over 70% of participants were White. Therefore, the study 
results may not generalize to other populations. Finally, 
changes in the dosage of blood pressure and cholesterol medi-
cations were not captured at the 24-month follow-up visit. 
  Additional analyses excluding individuals on medication 
were conducted, and with a few exceptions, the results did not 
change. These findings suggest that changes in medication 
did not produce the improvements in CVD risk factors.
Interventions that can be implemented nationwide and that 
result in meaningful population-wide changes in CVD risk 
factors are needed. To overcome the challenges and barriers 
associated with behavioral interventions delivered by physi-
cians in primary care settings, intervention protocols need to 
be parsimonious and efficient. Improvements in lipids from 
the ACT interventions could reduce the risk of CHD in people 
with already high levels of lipids by 16%–26% in men and 
11%–16% in women. From a public health perspective, these 
results are promising, as asking physicians to briefly counsel 
patients on PA during each visit may be realistic.54 Although 
significant improvements in CVD risk factors were found only 
among those with at-risk levels, it is important to note that PA 
provides other cardiovascular benefits beyond improvements 
in risk factor markers (ie, blood pressure, lipids), as well as 
mental health benefits. An innovative initiative launched by the 
American College of Sports Medicine and the American Medi-
cal Association, called Exercise is MedicineTM, is encouraging 
primary care physicians, as well as other health professionals, to 
include regular PA in treatment plans for patients.55 This initia-
tive recognizes the importance of regular PA and calls on health 
care providers to treat PA as a “vital sign”, which will result in 
the assessment and recording of PA at every clinic visit. The 
results from the present study provide support for the potential 
significance and success of such endeavors, particularly among 
individuals who may be in most need of changes.
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